{"title":"Reply to “The incidence of hepatitis flare and hepatic decompensation after nucleos(t)ide analogue cessation in chronic hepatitis B patients.”","authors":"Edo J. Dongelmans, Harry L.A. Janssen","doi":"10.1016/j.jhep.2024.11.044","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Clinical trial number</h2>not applicable.</section></section><section><section><h2>Author contributions</h2>Edo Dongelmans, MD (Conceptualization: Equal; Writing – original draft: Lead). Harry L.A. Janssen, MD, PhD (Conceptualization: Equal; Supervision: Lead; Writing – review & editing: Equal).</section></section><section><section><h2>Data availability statement</h2>not applicable.</section></section><section><section><h2>Financial support</h2>No funding was received for this article.</section></section><section><section><h2>Declaration of Competing Interest:</h2>Edo Dongelmans has no conflicts of interests. Harry Janssen received grants from: Gilead Sciences, GlaxoSmithKline, Janssen, Roche, Vir Biotechnology Inc. and is consultant for: Aligos, Gilead Sciences, GlaxoSmithKline, Janssen, Roche, Vir Biotechnology Inc., Precision Biosciences, Griffols.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"27 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.11.044","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Section snippets
Clinical trial number
not applicable.
Author contributions
Edo Dongelmans, MD (Conceptualization: Equal; Writing – original draft: Lead). Harry L.A. Janssen, MD, PhD (Conceptualization: Equal; Supervision: Lead; Writing – review & editing: Equal).
Data availability statement
not applicable.
Financial support
No funding was received for this article.
Declaration of Competing Interest:
Edo Dongelmans has no conflicts of interests. Harry Janssen received grants from: Gilead Sciences, GlaxoSmithKline, Janssen, Roche, Vir Biotechnology Inc. and is consultant for: Aligos, Gilead Sciences, GlaxoSmithKline, Janssen, Roche, Vir Biotechnology Inc., Precision Biosciences, Griffols.
期刊介绍:
The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.